01 · Markets & outlook

Markets & outlook

Erasca says 44% of 25 responded; it’s Phase 1 · No. 052 · · About 3 min read

Bookmarks need a Mind Club sign-in. How sign-in works

Markets & outlook across your briefs

All five benchmarks we track fell on Thursday. The S&P 500 ETF lost 2.0%, a sixth straight daily loss for the index, as reported, while the biotech ETFs fell less than 1%. The VIX rose to 28.44 from 24.56, and the 10-year yield eased to 5.04%.

Benchmark11.19 close1D1WYTDRead
XBI (equal-weight biotech)144.12−0.6%−4.7%+18.2%Fell less than the market
IBB (cap-weight biotech)203.72−0.8%−4.6%+20.7%Close to XBI on the day
XLV (health care)177.46−2.0%−5.5%+14.6%Fell with the market
SPY715.87−2.0%−5.4%+5.0%Sixth straight daily loss, as reported
IWM264.22−2.2%−5.1%+7.3%Small caps fell the most

Price returns from Robinhood market data: 1D vs 11.18, 1W vs 11.12, YTD vs 12.31.2025; dividends not included. VIX 28.44 at the 11.19 close, from 24.56 on 11.18, from Robinhood index data Data. The sixth straight loss for the S&P 500 is as reported by The Weekend Spread (11.19) Press.

Rates & macro

Fed funds target3.75 to 4.00%Held 10.28 by a 10 to 2 vote
UST 2Y / 10Y4.76% / 5.04%11.19; from 4.80% / 5.07% on 11.18
December FOMCHike priced, as reportedAbout 96% odds of a quarter-point hike at the 12.08 to 12.09 meeting, per CME FedWatch as reported by CappNotes (11.19)
VIX28.4411.19 close; 18.70 a week earlier

Biotech capital, YTD

IPOs31 / ~$9.3BBioBucks, updated 11.16; scope differs from our tally
M&A77 / ~$208.9BBioBucks, updated 11.16; disclosed value
Financings in windowNone countedIn our tally; see 07
Deals in windowAbbVie, DISCO$40M upfront; see 06

U.S. Treasury daily par yield curve (11.19) (opens another website in a new tab) Gov; FOMC statement (10.28) (opens another website in a new tab) and FOMC calendar (opens another website in a new tab) Gov; CME FedWatch as reported by CappNotes (11.19) Press; BioBucks IPO tracker (opens another website in a new tab) and M&A tracker (opens another website in a new tab) Data.

What moves the tape this week

A falling market and a VIX near 28 set the tone into the weekend, with a December hike still priced in futures, as reported. Biotech held up better than the broad market on Thursday, but one day of relative strength says little. Governors Waller and Cook are scheduled to speak on Friday. Analysis

RED TEAM

The FedWatch reading is secondhand, through a newsletter, and we did not read CME directly. We found no single cause for Thursday’s fall, and the brief does not track what drove the broad market. A day when biotech fell less than the market can reverse. Analysis